Approxima closed a € 1.6M seed financing round for the development of its minimally invasive
tricuspid valve repair technology and strengthens the team with both a new Chairman of the
Board and a CMO.
• The seed financing round was led by Panakès Partners alongside Club degli Investitori and a group
of business angels.
• The company announces the appointment of Umberto Pasquali as Chairman of the Board and Dr.
Paolo Denti as Chief Medical Officer.
Read more: panakes.it
